GLP-1, or Glucagon-Like Peptide-1, is a hormone that helps to regulate blood sugar levels
Clinical trials show an average weight loss of 1522% of baseline body weight over 68 weeks, though monthly progress follows a pattern influenced by genetics and individual metabolism
Among the most promising developments is the use of GLP-1 (glucagon-like peptide-1) medications for weight loss
Women experiencing moderate to severe hot flashes, particularly those who are unable or unwilling to take hormone replacement therapy, might find relief with GLP-1s
However, amid the frustration, there is a glimmer of hope
Hypoxia leads to the accumulation of UA precursors and the activation of xanthine oxidase/dehydrogenase further increase the level of UA in the body (Swan et al., 1994)